Yuhan's lung cancer drug Leclaza [YUHAN] Pharma firm Yuhan will supply its domestically-developed lung cancer drug Leclaza for free until it is covered by national health insurance in Korea. Yuhan's Leclaza was approved by the Ministry of Food and Drug Safety on June 30 for first-line chemotherapy, after the regulator gave the green light for the medication for second-line treatment in 2021. Under the early access program, which allows the medication to be provided to patients before it becomes eligible for insurance coverage, Yuhan will accept applications from secondary and tertiary medical facilities and temporarily offer free supplies of its Leclaza to an unlimited number of patients.

https://n.news.naver.com/mnews/article/640/0000040607?sid=101

#naver